Flagship startup loses CEO to Ipsen; Ionis to shed nearly six decades of board experience
Flagship旗下初创公司首席执行官跳槽至Ipsen；Ionis将失去近六十年的董事会经验

→ Michelle Werner has stepped down as CEO of Flagship startup Alltrna, saying on LinkedIn that the decision “is the right one for me and my family,” and she’s headed to Ipsen as president of North America on March 23. She closes out a four-year tenure after joining Alltrna and Flagship from Novartis, where she was the global franchise head for solid tumors. Werner had worked on advancing a pipeline of tRNA assets at the startup, with a lead program currently in IND-enabling studies.
→ 米歇尔•沃纳已卸任Flagship旗下初创公司Alltrna的首席执行官，她在领英表示这一决定“对我和我的家庭来说是正确的”，并将于3月23日出任易普生北美区总裁。沃纳自从从诺华离职（其时担任实体瘤manbetx app苹果 事业部负责人）并加入Alltrna和Flagship以来，已在此任职四年。她此前在该初创公司推进tRNA资产管线，领先项目目前处于IND申报支持性研究阶段。